January 7, 2022
Announcement of Personnel Changes
Mitsubishi Chemical Holdings Corporation
- Management Structure
- Changes in Corporate Executive Officers and Executive Officers
- Changes in Presidents and Executive Officers of Group Companies (Mitsubishi Chemical Corporation, Mitsubishi Tanabe Pharma
Corporation and Life Science Institute, Inc.)
IV. Corporate Executive Officers (as of April 1, 2022)
For further information, please contact:
Corporate Communications Office: Tel + [81] (3) -6748-7140
- Management Structure
- In its new management policy "Forging the future", announced on 1 December 2021, Mitsubishi Chemical Holdings Corporation (MCHC) announced its management structure from 1 April 2022. For more details, please refer to the attached press release "4. Leaner Structure to Execute Strategy".https://www.mitsubishichem-hd.co.jp/english/ir/01168.html
- In view of the significance of the new management structure, which will enable the Group to implement its strategy in an integrated manner, MCHC's subsidiaries, namely Mitsubishi Chemical Corporation, Mitsubishi Tanabe Pharma Corporation and Life Science Institute, Inc., will not have a President and Executive Officers from 1 April 2022. In these subsidiaries, the representative director represents the entity and executes the business on its behalf.
- "Executive Vice President" and "Senior Vice President" will be used in place of Managing Corporate Executive Officer, etc.as the titles of officers in charge of corporate and business divisions.
- Changes in Corporate Executive Officers and Executive Officers (as of April 1, 2022)
1. Corporate Executive Officers
New | Current | Name | ||
| Director of the Board | |||
| Director of the Board | Managing Corporate Executive Officer, Chief Financial Officer | Hidefumi Date※ | |
Supervising - Corporate Management Division, Corporate Communications | ||||
Office (IR) | ||||
| Executive Vice President, Head of Petrochemical & Coal business | | Representative Managing Corporate Executive Officer | |
| Representative Director, Director of the Board of Mitsubishi Chemical | Supervising - Corporate Strategy Division, Corporate Communications | Yoshihiro Ikegawa | |
Corporation | Office (Branding) | |||
| Director of the Board of Mitsubishi Chemical Corporation | |||
| Director of the Board | |||
Executive Vice President, Chief Compliance Officer | | Director of the Board | ||
General Counsel | Managing Corporate Executive Officer, Chief Group Compliance Officer | Ken Fujiwara | ||
Supervising - legal, internal control, admin, HR and corporate | Supervising -Corporate Administration Division, Administration Office | |||
administration | (Administration, Secretary) | |||
| Director of the Board of Mitsubishi Chemical Corporation | |||
| Executive Vice President, Chief Financial Officer | Yuko Nakahira ※ | ||
Supervising - finance, communication, IR and government affairs | ||||
| Senior Vice President, Chief Technology Officer | | Managing Corporate Executive Officer | Larry Meixner |
| Senior Vice President | | Corporate Executive Officer | |
Supervising - government affairs | Supervising - Corporate Communications Office (PR); Administration Office | Shigeki Habuka | ||
(Public Policy and Relation) | ||||
| Representative Corporate Executive Officer, Executive Vice President | | Representative Director, Director of the Board, | |
Chief Supply Chain Officer | Managing Executive Officer Supervising- Supply Chains of Mitsubishi | Nobuo Fukuda | ||
| Representative Director, Director of the Board of Mitsubishi Chemical | Chemical Corporation | ||
Corporation | ||||
| Executive Vice President | | Director of the Board, Managing Executive Officer, | |
Head of Films & Molding Materials / Advanced Solutions | Chief Operating Officer, Advanced Solutions Domain of Mitsubishi | Johei Takimoto | ||
Chemical Corporation | ||||
| Executive Vice President | | Director of the Board, Managing Executive Officer, | Hitoshi Sasaki |
Head of Polymers & Compounds / MMA | Chief Operating Officer, MMA Domain of Mitsubishi Chemical Corporation | |||
| Executive Vice President | President & Representative Director, Chief Executive Officer of Mitsubishi | |
Head of Pharma | Tanabe Pharma Corporation | Hiroaki Ueno | |
| Representative Director of Mitsubishi Tanabe Pharma Corporation | ||
※The transfer of Hidefumi Date and the appointment of Yuko Nakahira as Chief Financial Officer were previously announced on November 26, 2021.
2. Executive Officers
New | Current | Name | ||
| Vice President, Chief Strategy Officer | Joseph Rinaldi | ||
| Vice President, Chief Human Resource Officer | | General Manager, Human Resources Office | |
| General Manager, People Strategy Department, Mitsubishi Chemical | Tomoyo Hiraoka | ||
Corporation | ||||
- Changes in Directors and Executive Officers of Group Companies (April 1, 2022)
1. Mitsubishi Chemical Corporation
New | Current | Name | |
| Director of the Board | Representative Director, Director of the Board | Masayuki Waga |
President & CEO | |||
| Representative Director, Director of the Board | Representative Director, Director of the Board | |
| Representative Corporate Executive Officer, Executive Vice President, | Managing Executive Officer, Supervising- Supply Chains | Nobuo Fukuda |
Chief Supply Chain Officer of Mitsubishi Chemical Holdings Corporation | |||
| Executive Vice President, Head of Films & Molding Materials / Advanced | Director of the Board, Managing Executive Officer | Johei Takimoto |
Solutions of Mitsubishi Chemical Holdings Corporation | Chief Operating Officer, Advanced Solutions Domain | ||
| Executive Vice President, Head of Polymers & Compounds / MMA of | Director of the Board, Managing Executive Officer | Hitoshi Sasaki |
Mitsubishi Chemical Holdings Corporation | Chief Operating Officer, MMA Domain | ||
| Representative Director, Director of the Board | Director of the Board | |
| Executive Vice President, Head of Petrochemical & Coal business of | Representative Managing Corporate Executive Officer, Supervising - | Yoshihiro Ikegawa |
Mitsubishi Chemical Holdings Corporation | Corporate Strategy Division, Corporate Communications Office (Branding) | ||
of Mitsubishi Chemical Holdings Corporation | |||
| Director of the Board | Director of the Board, Managing Corporate Executive Officer, | |
| Director of the Board, Executive Vice President, Chief Compliance Officer | Chief Group Compliance Officer | |
General Counsel | Supervising -Corporate Administration Division, Administration Office | Ken Fujiwara | |
Supervising - legal, internal control, admin, HR and corporate | (Administration, Secretary) of Mitsubishi Chemical Holdings Corporation | ||
administration of Mitsubishi Chemical Holdings Corporation | |||
2. Mitsubishi Tanabe Pharma Corporation
New | Current | Name | |
| Representative Director, Director of the Board | President & Representative Director, Chief Executive Officer | |
| Executive Vice President, Head of Pharma of Mitsubishi Chemical | Hiroaki Ueno | |
Holdings Corporation | |||
3. | Life Science Institute, Inc. | ||
New | Current | Name | |
| Director of the Board | Representative Director, Director of the Board, President and Chief | Seiichi Kiso |
Executive Officer | |||
※The representative director of Life Sciences Institute, Inc. from April 1, 2022 onwards will be announced in due course. |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Mitsubishi Chemical Holdings Corporation published this content on 07 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 January 2022 04:07:03 UTC.